There are Excel functions that provide Mean (average) and Standard Deviation for a data series and you can use these to give you the same check.
You'll get a better result if you do it across the largest data set that you have.Thank you again, Smidge. And do you do and compare just weekly SD figures? I'm thinking days too micro to be useful.
And then also for each period where you want to compare something, no? - For me, eg, basal only cf. basal bolus.You'll get a better result if you do it across the largest data set that you have.
You can do this, yes, but make sure you are clear about the parameters you are using and your dataset is clean.And then also for each period where you want to compare something, no? - For me, eg, basal only cf. basal bolus.
Thank you again, Smidge. And do you do and compare just weekly SD figures? I'm thinking days too micro to be useful.
The argument that it should be use comes very much from the 'side' that considers intra daily variability important.That MAGE value is an interesting one. Following the instructions that are given in the ehow, I initially ended up with a MAGE that is 4.1
Taking a further look at the dataset, I can see that some of these are due to gaps in the data, most likely where my sensor has been replaced so I discount these. This leaves me with a result of 3.8.
Digging into these occurrences of notable change, there are 13 of them and I can see that in every case they are either the result of compensating for a hypo, or the follow up to a correction dose of insulin.
I'm therefore not entirely sure what MAGE is usefully indicating!
Kilpatrick did do some further analysis of the same data using MAGE and said this didn't make any difference either.(but the DCCTdidn't use CGM)Consider two patients with type 2 diabetes who have similar A1C and SD of glucose fluctuations around the mean. Assume that one subject has many minor glucose fluctuations and one or two major swings per day, whereas the other patient exhibits moderate glucose fluctuations over 24 h. Despite similar SD of glucose around the mean, these two patients should exhibit very different MAGE values, and thus Kilpatrick's use of SD as a definitive measure of glucose variability is questionable. Even though the MAGE determination requires continuous glucose monitoring, our opinion is that this index should be the gold standard for assessing glucose fluctuations in all prospective interventional trials designed to estimate glucose variability.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?